

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | peptide hormone processing (GO:0016486) | 7.22104202 |
| 2 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.20226541 |
| 3 | signal peptide processing (GO:0006465) | 6.82917921 |
| 4 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.72155031 |
| 5 | endocrine pancreas development (GO:0031018) | 6.67182247 |
| 6 | auditory receptor cell differentiation (GO:0042491) | 6.45142171 |
| 7 | positive regulation of insulin secretion (GO:0032024) | 6.31386054 |
| 8 | protein retention in ER lumen (GO:0006621) | 6.29274715 |
| 9 | COPII vesicle coating (GO:0048208) | 6.27813569 |
| 10 | sequestering of metal ion (GO:0051238) | 6.19604473 |
| 11 | macroautophagy (GO:0016236) | 5.93326606 |
| 12 | glandular epithelial cell differentiation (GO:0002067) | 5.62919010 |
| 13 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 5.48440843 |
| 14 | positive regulation of peptide hormone secretion (GO:0090277) | 5.16767214 |
| 15 | protein maturation by protein folding (GO:0022417) | 5.16178383 |
| 16 | negative regulation of JUN kinase activity (GO:0043508) | 5.04922073 |
| 17 | inositol phosphate dephosphorylation (GO:0046855) | 4.99411307 |
| 18 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 4.99411307 |
| 19 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.99377362 |
| 20 | positive regulation of peptide secretion (GO:0002793) | 4.98374654 |
| 21 | response to dietary excess (GO:0002021) | 4.96791015 |
| 22 | nodal signaling pathway (GO:0038092) | 4.95647854 |
| 23 | insulin secretion (GO:0030073) | 4.93110290 |
| 24 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.92344203 |
| 25 | ER overload response (GO:0006983) | 4.80800457 |
| 26 | regulation of insulin secretion (GO:0050796) | 4.77968493 |
| 27 | vitamin D metabolic process (GO:0042359) | 4.67295145 |
| 28 | vesicle coating (GO:0006901) | 4.66308139 |
| 29 | inositol phosphate catabolic process (GO:0071545) | 4.57849602 |
| 30 | inositol phosphate-mediated signaling (GO:0048016) | 4.44661099 |
| 31 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.42672407 |
| 32 | regulation of peptide hormone secretion (GO:0090276) | 4.40627746 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.38264584 |
| 34 | protein carboxylation (GO:0018214) | 4.38264584 |
| 35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.37683985 |
| 36 | regulation of glucocorticoid secretion (GO:2000849) | 4.37153265 |
| 37 | energy homeostasis (GO:0097009) | 4.36673243 |
| 38 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.34451062 |
| 39 | regulation of peptide secretion (GO:0002791) | 4.32078489 |
| 40 | cellular zinc ion homeostasis (GO:0006882) | 4.19501482 |
| 41 | peptide hormone secretion (GO:0030072) | 4.13109102 |
| 42 | positive regulation of hormone secretion (GO:0046887) | 4.11911740 |
| 43 | positive regulation of nuclease activity (GO:0032075) | 4.10866344 |
| 44 | hair cell differentiation (GO:0035315) | 4.10379535 |
| 45 | positive regulation of macroautophagy (GO:0016239) | 4.10176986 |
| 46 | carnitine transport (GO:0015879) | 4.09240752 |
| 47 | amino-acid betaine transport (GO:0015838) | 4.09240752 |
| 48 | synaptic vesicle maturation (GO:0016188) | 4.03250203 |
| 49 | peptide secretion (GO:0002790) | 4.00797467 |
| 50 | regulation of autophagic vacuole assembly (GO:2000785) | 4.00418962 |
| 51 | growth hormone secretion (GO:0030252) | 3.98018043 |
| 52 | positive regulation of glycolytic process (GO:0045821) | 3.94260616 |
| 53 | toxin metabolic process (GO:0009404) | 3.93619584 |
| 54 | glandular epithelial cell development (GO:0002068) | 3.90563091 |
| 55 | regulation of hormone secretion (GO:0046883) | 3.89685926 |
| 56 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 3.89622448 |
| 57 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.87246661 |
| 58 | negative regulation of digestive system process (GO:0060457) | 3.84991785 |
| 59 | protein autoprocessing (GO:0016540) | 3.81073589 |
| 60 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.79314961 |
| 61 | regulation of nuclease activity (GO:0032069) | 3.78512438 |
| 62 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.74975885 |
| 63 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.73259649 |
| 64 | epithelial cell fate commitment (GO:0072148) | 3.73048241 |
| 65 | polyol catabolic process (GO:0046174) | 3.72689729 |
| 66 | artery smooth muscle contraction (GO:0014824) | 3.70211203 |
| 67 | GDP-mannose metabolic process (GO:0019673) | 3.66183464 |
| 68 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.65728846 |
| 69 | toxin transport (GO:1901998) | 3.65216981 |
| 70 | organic cation transport (GO:0015695) | 3.63873350 |
| 71 | cellular response to leptin stimulus (GO:0044320) | 3.63412286 |
| 72 | cellular response to unfolded protein (GO:0034620) | 3.61709350 |
| 73 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.61457379 |
| 74 | regulation of vacuole organization (GO:0044088) | 3.60623006 |
| 75 | cellular response to topologically incorrect protein (GO:0035967) | 3.58650646 |
| 76 | negative regulation of gluconeogenesis (GO:0045721) | 3.56515009 |
| 77 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.56238501 |
| 78 | positive regulation of vesicle fusion (GO:0031340) | 3.54753206 |
| 79 | inner ear receptor cell differentiation (GO:0060113) | 3.52235672 |
| 80 | inner ear receptor cell development (GO:0060119) | 3.50455401 |
| 81 | type B pancreatic cell development (GO:0003323) | 3.50244026 |
| 82 | regulation of peptide transport (GO:0090087) | 3.49239898 |
| 83 | cellular response to vitamin D (GO:0071305) | 3.43742197 |
| 84 | hormone secretion (GO:0046879) | 3.42241399 |
| 85 | exocrine pancreas development (GO:0031017) | 3.41717128 |
| 86 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.41585523 |
| 87 | ER-nucleus signaling pathway (GO:0006984) | 3.38966248 |
| 88 | negative regulation of insulin secretion (GO:0046676) | 3.38925090 |
| 89 | cellular response to glucagon stimulus (GO:0071377) | 3.38530348 |
| 90 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37731178 |
| 91 | positive regulation of amino acid transport (GO:0051957) | 3.33961881 |
| 92 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.33730699 |
| 93 | nitric oxide mediated signal transduction (GO:0007263) | 3.33610001 |
| 94 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.32876418 |
| 95 | peptide metabolic process (GO:0006518) | 3.32812751 |
| 96 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.30484339 |
| 97 | peptide catabolic process (GO:0043171) | 3.28411231 |
| 98 | astrocyte differentiation (GO:0048708) | 3.27872629 |
| 99 | detection of calcium ion (GO:0005513) | 3.26236633 |
| 100 | cellular ketone body metabolic process (GO:0046950) | 3.25078323 |
| 101 | positive regulation of response to nutrient levels (GO:0032109) | 3.24108681 |
| 102 | positive regulation of response to extracellular stimulus (GO:0032106) | 3.24108681 |
| 103 | photoreceptor cell differentiation (GO:0046530) | 3.23331361 |
| 104 | eye photoreceptor cell differentiation (GO:0001754) | 3.23331361 |
| 105 | chemosensory behavior (GO:0007635) | 3.23096422 |
| 106 | peptide transport (GO:0015833) | 3.23050548 |
| 107 | hormone transport (GO:0009914) | 3.23009151 |
| 108 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.20381926 |
| 109 | peptidyl-asparagine modification (GO:0018196) | 3.17326967 |
| 110 | tonic smooth muscle contraction (GO:0014820) | 3.15126900 |
| 111 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.13978809 |
| 112 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.11531396 |
| 113 | zinc ion homeostasis (GO:0055069) | 3.09650040 |
| 114 | neuromuscular process controlling posture (GO:0050884) | 3.09276456 |
| 115 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.08644879 |
| 116 | endocrine process (GO:0050886) | 3.08644879 |
| 117 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.08644879 |
| 118 | response to endoplasmic reticulum stress (GO:0034976) | 3.05621038 |
| 119 | regulation of glucokinase activity (GO:0033131) | 3.04892534 |
| 120 | regulation of hexokinase activity (GO:1903299) | 3.04892534 |
| 121 | response to leptin (GO:0044321) | 3.04194748 |
| 122 | blood coagulation, intrinsic pathway (GO:0007597) | 3.03955542 |
| 123 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02487552 |
| 124 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.01542715 |
| 125 | nitric oxide biosynthetic process (GO:0006809) | 2.99979217 |
| 126 | single strand break repair (GO:0000012) | 2.99965633 |
| 127 | pharyngeal system development (GO:0060037) | 2.98515418 |
| 128 | piRNA metabolic process (GO:0034587) | 2.98128673 |
| 129 | protein N-linked glycosylation (GO:0006487) | 2.95164322 |
| 130 | negative regulation of peptide hormone secretion (GO:0090278) | 2.93438214 |
| 131 | beta-amyloid metabolic process (GO:0050435) | 2.92629235 |
| 132 | glucose homeostasis (GO:0042593) | 2.92328748 |
| 133 | carbohydrate homeostasis (GO:0033500) | 2.92328748 |
| 134 | positive regulation of calcium ion import (GO:0090280) | 2.90907192 |
| 135 | response to hexose (GO:0009746) | 2.89527039 |
| 136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.88235369 |
| 137 | L-phenylalanine catabolic process (GO:0006559) | 2.88235369 |
| 138 | norepinephrine metabolic process (GO:0042415) | 2.87984591 |
| 139 | brain morphogenesis (GO:0048854) | 2.87080345 |
| 140 | positive regulation of action potential (GO:0045760) | 2.86265032 |
| 141 | positive regulation of gluconeogenesis (GO:0045722) | 2.85440329 |
| 142 | negative regulation of catecholamine secretion (GO:0033604) | 2.85206368 |
| 143 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.85073060 |
| 144 | zinc ion transmembrane transport (GO:0071577) | 2.83590026 |
| 145 | ketone body metabolic process (GO:1902224) | 2.83516398 |
| 146 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.83280204 |
| 147 | regulation of neurotransmitter uptake (GO:0051580) | 2.81949847 |
| 148 | quaternary ammonium group transport (GO:0015697) | 2.81874299 |
| 149 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.79417585 |
| 150 | calcium ion import (GO:0070509) | 2.77735307 |
| 151 | positive regulation of glucose metabolic process (GO:0010907) | 2.77338981 |
| 152 | phosphate ion homeostasis (GO:0055062) | 2.77306848 |
| 153 | trivalent inorganic anion homeostasis (GO:0072506) | 2.77306848 |
| 154 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.74467647 |
| 155 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.74467647 |
| 156 | regulation of action potential (GO:0098900) | 2.73793037 |
| 157 | regulation of extracellular matrix disassembly (GO:0010715) | 2.72991215 |
| 158 | nonmotile primary cilium assembly (GO:0035058) | 2.70226437 |
| 159 | regulation of telomerase activity (GO:0051972) | 2.68737705 |
| 160 | catechol-containing compound biosynthetic process (GO:0009713) | 2.68665017 |
| 161 | catecholamine biosynthetic process (GO:0042423) | 2.68665017 |
| 162 | cerebellar Purkinje cell layer development (GO:0021680) | 2.68089533 |
| 163 | sphingomyelin metabolic process (GO:0006684) | 2.67712690 |
| 164 | COPI coating of Golgi vesicle (GO:0048205) | 11.0920593 |
| 165 | Golgi transport vesicle coating (GO:0048200) | 11.0920593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 4.36747855 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.49970724 |
| 3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.33122870 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.96051686 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.68976187 |
| 6 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.65109034 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.58866813 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.02848017 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 10.8928269 |
| 10 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.97193177 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.95198955 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94562440 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.88638763 |
| 14 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.84660609 |
| 15 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.81031146 |
| 16 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.79237052 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76377830 |
| 18 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.74720518 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69298531 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68369636 |
| 21 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.67993064 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.64469385 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64445147 |
| 24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.64075333 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63523146 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57525714 |
| 27 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.56342045 |
| 28 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.55610598 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55256982 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53407041 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.51180390 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48518811 |
| 33 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.48502274 |
| 34 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.46340865 |
| 35 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41654284 |
| 36 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.40874426 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39839513 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37835897 |
| 39 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.35506668 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.34846858 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34587984 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33445420 |
| 43 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32043975 |
| 44 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31821751 |
| 45 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.31527272 |
| 46 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29178374 |
| 47 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28971244 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28958087 |
| 49 | NCOR_22424771_ChIP-Seq_293T_Human | 1.26302927 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25769534 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25711689 |
| 52 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.24854145 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.23935715 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23738850 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23413034 |
| 56 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22732866 |
| 57 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21364846 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20535786 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20182850 |
| 60 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19564248 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19244106 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19211906 |
| 63 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19041157 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18268944 |
| 65 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.18142074 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17595753 |
| 67 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.16935721 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16332282 |
| 69 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.14541168 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12356907 |
| 71 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11966827 |
| 72 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11855395 |
| 73 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.11736330 |
| 74 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11111398 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10292067 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.10073468 |
| 77 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09806735 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.09300676 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09196380 |
| 80 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08887727 |
| 81 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.07675369 |
| 82 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06707478 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06400274 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05926337 |
| 85 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05698729 |
| 86 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05698080 |
| 87 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05400851 |
| 88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05400851 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.03890001 |
| 90 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03170805 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03089086 |
| 92 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02714709 |
| 93 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02520107 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.02102864 |
| 95 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.01139157 |
| 96 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.00803051 |
| 97 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99979002 |
| 98 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99751748 |
| 99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99468086 |
| 100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99400857 |
| 101 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.99145916 |
| 102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.99044445 |
| 103 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98348410 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97989085 |
| 105 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96932996 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96673451 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96544665 |
| 108 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.95176849 |
| 109 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94123111 |
| 110 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94123111 |
| 111 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.93787587 |
| 112 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.93514629 |
| 113 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93507738 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93171110 |
| 115 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93110074 |
| 116 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92791670 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92537210 |
| 118 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91686581 |
| 119 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.91544678 |
| 120 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.91033168 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90671005 |
| 122 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90463891 |
| 123 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.88907109 |
| 124 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.88613847 |
| 125 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.87451583 |
| 126 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87143754 |
| 127 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.85211666 |
| 128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85096883 |
| 129 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83094059 |
| 130 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.82709766 |
| 131 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82421335 |
| 132 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80878301 |
| 133 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.80780516 |
| 134 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.80780516 |
| 135 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79932933 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78672182 |
| 137 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78407601 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.78086464 |
| 139 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78062428 |
| 140 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.77358297 |
| 141 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76865852 |
| 142 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.76678550 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76182602 |
| 144 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.76010049 |
| 145 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75534987 |
| 146 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.75070636 |
| 147 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.74803445 |
| 148 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.74070807 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73102758 |
| 150 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72642689 |
| 151 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.72534294 |
| 152 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.72256115 |
| 153 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.71554629 |
| 154 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.71217755 |
| 155 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.71196224 |
| 156 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.70931925 |
| 157 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.70618079 |
| 158 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.70281756 |
| 159 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.70016971 |
| 160 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.69696903 |
| 161 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.69595626 |
| 162 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69563117 |
| 163 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.69390449 |
| 164 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.69353423 |
| 165 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.69146491 |
| 166 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69031675 |
| 167 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.68980720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000013_abnormal_adipose_tissue | 5.56714079 |
| 2 | MP0003195_calcinosis | 4.69207956 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.57860277 |
| 4 | MP0004043_abnormal_pH_regulation | 4.38852691 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 4.27561215 |
| 6 | MP0005379_endocrine/exocrine_gland_phen | 3.98172877 |
| 7 | MP0002693_abnormal_pancreas_physiology | 3.59602690 |
| 8 | MP0010386_abnormal_urinary_bladder | 3.54070386 |
| 9 | MP0002909_abnormal_adrenal_gland | 3.52342778 |
| 10 | MP0001944_abnormal_pancreas_morphology | 3.50830244 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 3.41559445 |
| 12 | MP0000003_abnormal_adipose_tissue | 3.30356714 |
| 13 | MP0003283_abnormal_digestive_organ | 3.14273702 |
| 14 | MP0005645_abnormal_hypothalamus_physiol | 2.94399865 |
| 15 | MP0000678_abnormal_parathyroid_gland | 2.80440437 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 2.66800973 |
| 17 | MP0005220_abnormal_exocrine_pancreas | 2.64419414 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.57891303 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.52075378 |
| 20 | MP0008877_abnormal_DNA_methylation | 2.39438499 |
| 21 | MP0008004_abnormal_stomach_pH | 2.35731605 |
| 22 | MP0003122_maternal_imprinting | 2.16942186 |
| 23 | MP0002078_abnormal_glucose_homeostasis | 2.15142228 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.00533435 |
| 25 | MP0002638_abnormal_pupillary_reflex | 1.92416155 |
| 26 | MP0004270_analgesia | 1.88257634 |
| 27 | MP0004885_abnormal_endolymph | 1.79685780 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.70257188 |
| 29 | MP0002938_white_spotting | 1.67300719 |
| 30 | MP0002822_catalepsy | 1.66898171 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.58643414 |
| 32 | MP0005257_abnormal_intraocular_pressure | 1.57440453 |
| 33 | MP0002163_abnormal_gland_morphology | 1.57240801 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.56910676 |
| 35 | MP0005365_abnormal_bile_salt | 1.56891178 |
| 36 | MP0005409_darkened_coat_color | 1.54636804 |
| 37 | MP0001756_abnormal_urination | 1.50887894 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.50657205 |
| 39 | MP0006054_spinal_hemorrhage | 1.50364113 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.49349570 |
| 41 | MP0002751_abnormal_autonomic_nervous | 1.44555017 |
| 42 | MP0001529_abnormal_vocalization | 1.40235532 |
| 43 | MP0003959_abnormal_lean_body | 1.34864107 |
| 44 | MP0000613_abnormal_salivary_gland | 1.33782537 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.31829663 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 1.31371524 |
| 47 | MP0003953_abnormal_hormone_level | 1.31330762 |
| 48 | MP0009745_abnormal_behavioral_response | 1.26651577 |
| 49 | MP0005375_adipose_tissue_phenotype | 1.24187152 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.24104539 |
| 51 | MP0005248_abnormal_Harderian_gland | 1.21910703 |
| 52 | MP0004215_abnormal_myocardial_fiber | 1.20333702 |
| 53 | MP0002234_abnormal_pharynx_morphology | 1.19339977 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.18996839 |
| 55 | MP0009384_cardiac_valve_regurgitation | 1.17395480 |
| 56 | MP0002139_abnormal_hepatobiliary_system | 1.13820543 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.13058395 |
| 58 | MP0002896_abnormal_bone_mineralization | 1.10997423 |
| 59 | MP0004133_heterotaxia | 1.09116857 |
| 60 | MP0005408_hypopigmentation | 1.08338078 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.07630675 |
| 62 | MP0000538_abnormal_urinary_bladder | 1.07224237 |
| 63 | MP0004147_increased_porphyrin_level | 1.06893157 |
| 64 | MP0006082_CNS_inflammation | 1.06001871 |
| 65 | MP0003890_abnormal_embryonic-extraembry | 1.05332343 |
| 66 | MP0002928_abnormal_bile_duct | 1.03905138 |
| 67 | MP0000462_abnormal_digestive_system | 0.99945397 |
| 68 | MP0005253_abnormal_eye_physiology | 0.98474745 |
| 69 | MP0000372_irregular_coat_pigmentation | 0.98364126 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.97917309 |
| 71 | MP0009046_muscle_twitch | 0.97059493 |
| 72 | MP0006292_abnormal_olfactory_placode | 0.96060608 |
| 73 | MP0003868_abnormal_feces_composition | 0.95763032 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.95717781 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 0.94391286 |
| 76 | MP0004510_myositis | 0.94014241 |
| 77 | MP0001485_abnormal_pinna_reflex | 0.93871299 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.93822142 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.93242478 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 0.93191369 |
| 81 | MP0001270_distended_abdomen | 0.90266649 |
| 82 | MP0002064_seizures | 0.89399076 |
| 83 | MP0002295_abnormal_pulmonary_circulatio | 0.88595541 |
| 84 | MP0006276_abnormal_autonomic_nervous | 0.86440755 |
| 85 | MP0003119_abnormal_digestive_system | 0.85809492 |
| 86 | MP0002272_abnormal_nervous_system | 0.85272826 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.85271573 |
| 88 | MP0002254_reproductive_system_inflammat | 0.83537332 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.81838216 |
| 90 | MP0005535_abnormal_body_temperature | 0.81629961 |
| 91 | MP0002572_abnormal_emotion/affect_behav | 0.81140017 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.80736524 |
| 93 | MP0005448_abnormal_energy_balance | 0.80722318 |
| 94 | MP0003123_paternal_imprinting | 0.79850676 |
| 95 | MP0004019_abnormal_vitamin_homeostasis | 0.79663111 |
| 96 | MP0005310_abnormal_salivary_gland | 0.78031366 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.77631637 |
| 98 | MP0003787_abnormal_imprinting | 0.75899850 |
| 99 | MP0003300_gastrointestinal_ulcer | 0.75069084 |
| 100 | MP0004142_abnormal_muscle_tone | 0.74751756 |
| 101 | MP0005386_behavior/neurological_phenoty | 0.74066014 |
| 102 | MP0004924_abnormal_behavior | 0.74066014 |
| 103 | MP0003121_genomic_imprinting | 0.69568377 |
| 104 | MP0002063_abnormal_learning/memory/cond | 0.68827400 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.68777132 |
| 106 | MP0003879_abnormal_hair_cell | 0.68607002 |
| 107 | MP0002229_neurodegeneration | 0.67531220 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.66251761 |
| 109 | MP0001919_abnormal_reproductive_system | 0.65999671 |
| 110 | MP0002090_abnormal_vision | 0.65906170 |
| 111 | MP0002177_abnormal_outer_ear | 0.65015497 |
| 112 | MP0001905_abnormal_dopamine_level | 0.63392659 |
| 113 | MP0003252_abnormal_bile_duct | 0.63387378 |
| 114 | MP0004085_abnormal_heartbeat | 0.63129311 |
| 115 | MP0002166_altered_tumor_susceptibility | 0.62567171 |
| 116 | MP0005334_abnormal_fat_pad | 0.61653751 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.61153825 |
| 118 | MP0005452_abnormal_adipose_tissue | 0.59530503 |
| 119 | MP0002733_abnormal_thermal_nociception | 0.59206918 |
| 120 | MP0001968_abnormal_touch/_nociception | 0.58534946 |
| 121 | MP0005171_absent_coat_pigmentation | 0.58448960 |
| 122 | MP0009672_abnormal_birth_weight | 0.57388975 |
| 123 | MP0003880_abnormal_central_pattern | 0.56722851 |
| 124 | MP0002876_abnormal_thyroid_physiology | 0.56467398 |
| 125 | MP0009333_abnormal_splenocyte_physiolog | 0.56234732 |
| 126 | MP0001186_pigmentation_phenotype | 0.56190263 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.56058823 |
| 128 | MP0008057_abnormal_DNA_replication | 0.55694866 |
| 129 | MP0005332_abnormal_amino_acid | 0.55535670 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.55335806 |
| 131 | MP0003635_abnormal_synaptic_transmissio | 0.55073764 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.54817139 |
| 133 | MP0003631_nervous_system_phenotype | 0.54547946 |
| 134 | MP0003633_abnormal_nervous_system | 0.54256362 |
| 135 | MP0001664_abnormal_digestion | 0.54218764 |
| 136 | MP0001764_abnormal_homeostasis | 0.53776145 |
| 137 | MP0000681_abnormal_thyroid_gland | 0.52832456 |
| 138 | MP0004145_abnormal_muscle_electrophysio | 0.51469775 |
| 139 | MP0009642_abnormal_blood_homeostasis | 0.50353612 |
| 140 | MP0002557_abnormal_social/conspecific_i | 0.49492220 |
| 141 | MP0004233_abnormal_muscle_weight | 0.48895242 |
| 142 | MP0009703_decreased_birth_body | 0.43453614 |
| 143 | MP0002184_abnormal_innervation | 0.42339699 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.42019832 |
| 145 | MP0001970_abnormal_pain_threshold | 0.41578059 |
| 146 | MP0000955_abnormal_spinal_cord | 0.39230539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 8.24126021 |
| 2 | Hypoglycemic seizures (HP:0002173) | 7.97334489 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.18488499 |
| 4 | Hypoglycemic coma (HP:0001325) | 7.06956200 |
| 5 | Symptomatic seizures (HP:0011145) | 6.94913345 |
| 6 | Hyperglycemia (HP:0003074) | 5.67135378 |
| 7 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.17523314 |
| 8 | Late onset (HP:0003584) | 4.81364141 |
| 9 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.61650198 |
| 10 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.61650198 |
| 11 | Ketoacidosis (HP:0001993) | 4.59729954 |
| 12 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.58112249 |
| 13 | Congenital sensorineural hearing impairment (HP:0008527) | 4.29559328 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 4.25791402 |
| 15 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.09942780 |
| 16 | Joint hemorrhage (HP:0005261) | 3.99016804 |
| 17 | Large for gestational age (HP:0001520) | 3.76567534 |
| 18 | Agitation (HP:0000713) | 3.58774550 |
| 19 | Nuclear cataract (HP:0100018) | 3.53957962 |
| 20 | Dysautonomia (HP:0002459) | 3.51581573 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.48703805 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.40169633 |
| 23 | Double outlet right ventricle (HP:0001719) | 3.39027590 |
| 24 | Congenital malformation of the right heart (HP:0011723) | 3.39027590 |
| 25 | Proximal tubulopathy (HP:0000114) | 3.38886997 |
| 26 | Retinal atrophy (HP:0001105) | 3.36106034 |
| 27 | Prominent metopic ridge (HP:0005487) | 3.20602541 |
| 28 | Abnormal pancreas size (HP:0012094) | 3.16717296 |
| 29 | Mesangial abnormality (HP:0001966) | 3.13773277 |
| 30 | Hyperparathyroidism (HP:0000843) | 3.10259495 |
| 31 | Poor suck (HP:0002033) | 3.09741478 |
| 32 | Gingival bleeding (HP:0000225) | 3.07179032 |
| 33 | Pheochromocytoma (HP:0002666) | 3.04157410 |
| 34 | Renal cortical cysts (HP:0000803) | 2.96725993 |
| 35 | Orthostatic hypotension (HP:0001278) | 2.96022739 |
| 36 | Decreased circulating renin level (HP:0003351) | 2.94825572 |
| 37 | Medial flaring of the eyebrow (HP:0010747) | 2.90367705 |
| 38 | Osteomalacia (HP:0002749) | 2.89644717 |
| 39 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.88416772 |
| 40 | Hypoplasia of the fovea (HP:0007750) | 2.88416772 |
| 41 | Menstrual irregularities (HP:0000858) | 2.87441841 |
| 42 | Truncus arteriosus (HP:0001660) | 2.75626226 |
| 43 | Insulin resistance (HP:0000855) | 2.74687115 |
| 44 | Hypokalemia (HP:0002900) | 2.74458240 |
| 45 | Ketosis (HP:0001946) | 2.74071599 |
| 46 | Abnormality of the fovea (HP:0000493) | 2.73771850 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.67837539 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.67837539 |
| 49 | Abnormality of the metopic suture (HP:0005556) | 2.67600037 |
| 50 | Gout (HP:0001997) | 2.65182912 |
| 51 | Generalized aminoaciduria (HP:0002909) | 2.64603183 |
| 52 | Neuroendocrine neoplasm (HP:0100634) | 2.64085056 |
| 53 | Testicular atrophy (HP:0000029) | 2.57698880 |
| 54 | Abnormality of the intrinsic pathway (HP:0010989) | 2.56495161 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.55987531 |
| 56 | Postural tremor (HP:0002174) | 2.53415199 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51982161 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51982161 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51982161 |
| 60 | Testicular neoplasm (HP:0010788) | 2.50148256 |
| 61 | Hypothermia (HP:0002045) | 2.49309259 |
| 62 | Menorrhagia (HP:0000132) | 2.48839132 |
| 63 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48726777 |
| 64 | Sex reversal (HP:0012245) | 2.46174152 |
| 65 | Abnormal sex determination (HP:0012244) | 2.46174152 |
| 66 | Hyperkalemia (HP:0002153) | 2.43294268 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.43065201 |
| 68 | Intestinal atresia (HP:0011100) | 2.42465608 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.41359349 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.39941374 |
| 71 | Hyperphosphatemia (HP:0002905) | 2.39014319 |
| 72 | Muscular hypotonia of the trunk (HP:0008936) | 2.38316955 |
| 73 | Hypsarrhythmia (HP:0002521) | 2.38122908 |
| 74 | Abnormal albumin level (HP:0012116) | 2.37124431 |
| 75 | Hypoalbuminemia (HP:0003073) | 2.37124431 |
| 76 | Thin bony cortex (HP:0002753) | 2.36579084 |
| 77 | Abnormality of potassium homeostasis (HP:0011042) | 2.35295042 |
| 78 | Syncope (HP:0001279) | 2.34375353 |
| 79 | Hypotension (HP:0002615) | 2.34224883 |
| 80 | Hypercortisolism (HP:0001578) | 2.32951926 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.31883899 |
| 82 | Epileptiform EEG discharges (HP:0011182) | 2.31616402 |
| 83 | Episodic fever (HP:0001954) | 2.31021965 |
| 84 | Limb hypertonia (HP:0002509) | 2.29764315 |
| 85 | Type I transferrin isoform profile (HP:0003642) | 2.28461314 |
| 86 | Abnormality of vitamin B metabolism (HP:0004340) | 2.28135454 |
| 87 | Growth hormone excess (HP:0000845) | 2.28104028 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 2.27537919 |
| 89 | Restlessness (HP:0000711) | 2.26842616 |
| 90 | Enlarged epiphyses (HP:0010580) | 2.25433522 |
| 91 | Broad face (HP:0000283) | 2.24294024 |
| 92 | Anxiety (HP:0000739) | 2.24076985 |
| 93 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.23396476 |
| 94 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.23396476 |
| 95 | Abnormal protein glycosylation (HP:0012346) | 2.23396476 |
| 96 | Abnormal glycosylation (HP:0012345) | 2.23396476 |
| 97 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.22408121 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 2.22087285 |
| 99 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20095217 |
| 100 | Macroorchidism (HP:0000053) | 2.16735204 |
| 101 | Congenital primary aphakia (HP:0007707) | 2.15984521 |
| 102 | Villous atrophy (HP:0011473) | 2.14979784 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.14979784 |
| 104 | Abnormality of vitamin metabolism (HP:0100508) | 2.14657426 |
| 105 | Congenital cataract (HP:0000519) | 2.12422946 |
| 106 | Gait imbalance (HP:0002141) | 2.11964535 |
| 107 | Choreoathetosis (HP:0001266) | 2.10595340 |
| 108 | Blue irides (HP:0000635) | 2.10589349 |
| 109 | Thoracolumbar scoliosis (HP:0002944) | 2.09437122 |
| 110 | Enlarged penis (HP:0000040) | 2.09061261 |
| 111 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.08640955 |
| 112 | Spondylolisthesis (HP:0003302) | 2.08081725 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07722350 |
| 114 | Hypophosphatemia (HP:0002148) | 2.07033357 |
| 115 | Hyperthyroidism (HP:0000836) | 2.06774152 |
| 116 | Cardiomegaly (HP:0001640) | 2.06077062 |
| 117 | Anteriorly placed anus (HP:0001545) | 2.05281586 |
| 118 | Abnormality of chloride homeostasis (HP:0011422) | 2.05265453 |
| 119 | Unilateral renal agenesis (HP:0000122) | 2.03533434 |
| 120 | Bifid tongue (HP:0010297) | 2.02169683 |
| 121 | Gaze-evoked nystagmus (HP:0000640) | 2.02103061 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 2.00971157 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.00971157 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.00971157 |
| 125 | Focal segmental glomerulosclerosis (HP:0000097) | 2.00213782 |
| 126 | Diplopia (HP:0000651) | 1.99567301 |
| 127 | Abnormality of binocular vision (HP:0011514) | 1.99567301 |
| 128 | Severe muscular hypotonia (HP:0006829) | 1.94629600 |
| 129 | Absent speech (HP:0001344) | 1.92731313 |
| 130 | Hyperphosphaturia (HP:0003109) | 1.90861901 |
| 131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.89772190 |
| 132 | Vascular calcification (HP:0004934) | 1.89449917 |
| 133 | Hyperactive renin-angiotensin system (HP:0000841) | 1.87836379 |
| 134 | Generalized hyperpigmentation (HP:0007440) | 1.86324902 |
| 135 | Zonular cataract (HP:0010920) | 1.86248617 |
| 136 | Adrenal overactivity (HP:0002717) | 1.85109946 |
| 137 | Chronic bronchitis (HP:0004469) | 1.84835056 |
| 138 | Constricted visual fields (HP:0001133) | 1.83993355 |
| 139 | Increased circulating renin level (HP:0000848) | 1.83891556 |
| 140 | Nephrogenic diabetes insipidus (HP:0009806) | 1.81959731 |
| 141 | Abdominal distention (HP:0003270) | 1.81496366 |
| 142 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.77769896 |
| 143 | Urethral obstruction (HP:0000796) | 1.77548272 |
| 144 | Hemiparesis (HP:0001269) | 1.77508212 |
| 145 | Delayed epiphyseal ossification (HP:0002663) | 1.74398074 |
| 146 | Exocrine pancreatic insufficiency (HP:0001738) | 1.74385463 |
| 147 | Abnormality of the renal cortex (HP:0011035) | 1.73792001 |
| 148 | Abnormality of urine glucose concentration (HP:0011016) | 1.72533713 |
| 149 | Glycosuria (HP:0003076) | 1.72533713 |
| 150 | Abnormality of abdominal situs (HP:0011620) | 1.72524247 |
| 151 | Congenital glaucoma (HP:0001087) | 1.71697035 |
| 152 | Missing ribs (HP:0000921) | 1.70720006 |
| 153 | Enlarged kidneys (HP:0000105) | 1.69675351 |
| 154 | Neoplasm of the thyroid gland (HP:0100031) | 1.67605382 |
| 155 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.63348715 |
| 156 | Neoplasm of the adrenal gland (HP:0100631) | 1.61159539 |
| 157 | Disproportionate short-trunk short stature (HP:0003521) | 1.60480516 |
| 158 | Increased CSF protein (HP:0002922) | 1.60422289 |
| 159 | Type II lissencephaly (HP:0007260) | 1.60019359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 8.05151611 |
| 2 | WNK3 | 6.64501351 |
| 3 | INSRR | 5.91422006 |
| 4 | DAPK2 | 4.51205872 |
| 5 | TAOK1 | 3.64579346 |
| 6 | WNK4 | 3.54658925 |
| 7 | PIK3CG | 3.52269427 |
| 8 | TRIM28 | 3.51259245 |
| 9 | PASK | 3.42823500 |
| 10 | TRPM7 | 3.13194396 |
| 11 | MST4 | 3.01692743 |
| 12 | MAP4K2 | 2.80062680 |
| 13 | IRAK3 | 2.78077632 |
| 14 | FRK | 2.74695572 |
| 15 | PRKD3 | 2.43169926 |
| 16 | CSNK1G1 | 2.41108853 |
| 17 | MAP2K6 | 2.32818239 |
| 18 | CSNK1G3 | 2.19328622 |
| 19 | HIPK2 | 2.12599121 |
| 20 | MAP3K2 | 2.01451529 |
| 21 | UHMK1 | 1.88262907 |
| 22 | CSNK1A1L | 1.84759496 |
| 23 | GRK1 | 1.81422568 |
| 24 | CASK | 1.75200448 |
| 25 | STK3 | 1.71022462 |
| 26 | CSNK1G2 | 1.69159490 |
| 27 | TAOK3 | 1.66224775 |
| 28 | IRAK1 | 1.63251434 |
| 29 | ERN1 | 1.62490364 |
| 30 | DAPK1 | 1.52554226 |
| 31 | STK4 | 1.46754834 |
| 32 | CAMKK2 | 1.28020736 |
| 33 | FGFR3 | 1.26344188 |
| 34 | CDC42BPA | 1.25285587 |
| 35 | WNK1 | 1.24000799 |
| 36 | TLK1 | 1.23804972 |
| 37 | EPHA2 | 1.22977498 |
| 38 | PRKCG | 1.15352292 |
| 39 | MAP3K9 | 1.14352599 |
| 40 | EPHA3 | 1.11251423 |
| 41 | FGFR2 | 1.08714078 |
| 42 | BCR | 1.07908717 |
| 43 | BMPR1B | 1.07294988 |
| 44 | AKT3 | 1.03177250 |
| 45 | STK16 | 1.02464678 |
| 46 | PAK3 | 1.02437440 |
| 47 | DYRK1B | 1.00503222 |
| 48 | BCKDK | 0.99266602 |
| 49 | FLT3 | 0.97787195 |
| 50 | MAP3K1 | 0.94524331 |
| 51 | EPHA4 | 0.92379567 |
| 52 | BRD4 | 0.91975835 |
| 53 | NTRK1 | 0.90206656 |
| 54 | CAMK1D | 0.90072412 |
| 55 | DAPK3 | 0.88824608 |
| 56 | BRSK2 | 0.88179495 |
| 57 | PTK2 | 0.87362166 |
| 58 | IRAK2 | 0.86485354 |
| 59 | NTRK3 | 0.84343040 |
| 60 | TNK2 | 0.83066854 |
| 61 | IRAK4 | 0.80587177 |
| 62 | STK38 | 0.80382089 |
| 63 | BRAF | 0.80194267 |
| 64 | PINK1 | 0.78502516 |
| 65 | BMPR2 | 0.75864242 |
| 66 | PTK2B | 0.72731751 |
| 67 | PRKCI | 0.71736621 |
| 68 | MAP2K2 | 0.70146545 |
| 69 | MAPK11 | 0.70041893 |
| 70 | PHKG2 | 0.68650246 |
| 71 | PHKG1 | 0.68650246 |
| 72 | TESK1 | 0.67410689 |
| 73 | PRKD2 | 0.66617663 |
| 74 | CSK | 0.63683024 |
| 75 | SCYL2 | 0.62566968 |
| 76 | NLK | 0.62396668 |
| 77 | ERBB3 | 0.62275214 |
| 78 | CAMK2A | 0.60423487 |
| 79 | OXSR1 | 0.59488364 |
| 80 | MKNK2 | 0.58882614 |
| 81 | NEK1 | 0.58271146 |
| 82 | PTK6 | 0.57912872 |
| 83 | PRKCH | 0.57751636 |
| 84 | EIF2AK3 | 0.57427604 |
| 85 | EPHB1 | 0.55053654 |
| 86 | DYRK3 | 0.54914042 |
| 87 | TESK2 | 0.53203090 |
| 88 | KSR2 | 0.53045938 |
| 89 | CAMK1G | 0.50727238 |
| 90 | YES1 | 0.50125345 |
| 91 | FER | 0.49783848 |
| 92 | FES | 0.48586721 |
| 93 | PDGFRA | 0.47692289 |
| 94 | CAMK2D | 0.47473668 |
| 95 | CSNK1D | 0.45560083 |
| 96 | ATM | 0.45386835 |
| 97 | MAP3K4 | 0.44267971 |
| 98 | STK11 | 0.43399409 |
| 99 | STK38L | 0.42413189 |
| 100 | PRKG2 | 0.42062195 |
| 101 | PRKCE | 0.41045497 |
| 102 | CSF1R | 0.39577699 |
| 103 | PDK1 | 0.39363321 |
| 104 | BRSK1 | 0.38170712 |
| 105 | RPS6KA5 | 0.36911809 |
| 106 | ITK | 0.36853121 |
| 107 | DYRK1A | 0.35774282 |
| 108 | SGK494 | 0.34842932 |
| 109 | SGK223 | 0.34842932 |
| 110 | LMTK2 | 0.34184820 |
| 111 | KSR1 | 0.34130631 |
| 112 | CAMK4 | 0.33684355 |
| 113 | RPS6KB1 | 0.32498732 |
| 114 | AKT2 | 0.32117309 |
| 115 | FGFR1 | 0.31471030 |
| 116 | TBK1 | 0.31074412 |
| 117 | ZAK | 0.30416091 |
| 118 | PRKG1 | 0.29815508 |
| 119 | RET | 0.27789079 |
| 120 | CSNK1A1 | 0.27639563 |
| 121 | TEC | 0.27106414 |
| 122 | MET | 0.26617811 |
| 123 | FGFR4 | 0.26437003 |
| 124 | FGR | 0.25333054 |
| 125 | ADRBK2 | 0.24957980 |
| 126 | TNIK | 0.24417008 |
| 127 | ACVR1B | 0.24219591 |
| 128 | MAPKAPK3 | 0.23954316 |
| 129 | MAP2K1 | 0.23846558 |
| 130 | PRPF4B | 0.23155400 |
| 131 | PRKAA1 | 0.23047784 |
| 132 | SIK1 | 0.22797123 |
| 133 | PRKDC | 0.22397343 |
| 134 | ROCK2 | 0.22371045 |
| 135 | CSNK1E | 0.22294994 |
| 136 | CAMK2B | 0.21338775 |
| 137 | CHUK | 0.20598793 |
| 138 | SGK2 | 0.20419564 |
| 139 | MTOR | 0.20319324 |
| 140 | CDK5 | 0.19891323 |
| 141 | NEK6 | 0.18859674 |
| 142 | PRKACA | 0.18821683 |
| 143 | PRKACG | 0.18717038 |
| 144 | JAK2 | 0.18494137 |
| 145 | GSK3A | 0.17306882 |
| 146 | ERBB4 | 0.16424278 |
| 147 | ADRBK1 | 0.15354891 |
| 148 | DYRK2 | 0.15288649 |
| 149 | IGF1R | 0.15173887 |
| 150 | LIMK1 | 0.14833378 |
| 151 | MAPK10 | 0.14034097 |
| 152 | SGK1 | 0.11547852 |
| 153 | RPS6KA2 | 0.10868169 |
| 154 | PRKCA | 0.10284470 |
| 155 | RPS6KA3 | 0.10210054 |
| 156 | MAPK3 | 0.09262924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.12453430 |
| 2 | Protein export_Homo sapiens_hsa03060 | 6.44486397 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.47653750 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 3.32190731 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.16961046 |
| 6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.35195892 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.06829815 |
| 8 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.78673965 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76202721 |
| 10 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.75873676 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.73043666 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.71697533 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59735799 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55687060 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53970219 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53344352 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53172122 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50672987 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.49180345 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48649788 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.45203254 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.43468630 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.39179422 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.38808566 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31961930 |
| 26 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.31723582 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24312966 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.19311977 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.17208138 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16812932 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.16762109 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.12628774 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10535795 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05536971 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04261094 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01406282 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.00454963 |
| 38 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99985082 |
| 39 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94564042 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89490400 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88394218 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88174476 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87000078 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85944625 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83620510 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82234152 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 0.81141916 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79438253 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79279061 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77476636 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77255141 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76091412 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74791878 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.74620173 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74293965 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 0.73730946 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73607171 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73398377 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72203267 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70745336 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69703572 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69137329 |
| 63 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67731005 |
| 64 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66164874 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62413207 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62072745 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62016791 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59243273 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58177054 |
| 70 | Alcoholism_Homo sapiens_hsa05034 | 0.57967786 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56583230 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.56189657 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54450949 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51300565 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50905854 |
| 76 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50117476 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50055477 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49798237 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.48994155 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48765754 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48340740 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47959061 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.46020236 |
| 84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45318146 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.45020836 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.42767502 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40671839 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.40134134 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.39955258 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.38496007 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.37911637 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37494502 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37242498 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37136270 |
| 95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37106645 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37041215 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.36874409 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35969790 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.31027547 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30959382 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30295381 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29872698 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28925169 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28496045 |
| 105 | Lysine degradation_Homo sapiens_hsa00310 | 0.26935246 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.26896669 |
| 107 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.26290857 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.25994677 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.25680434 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25298383 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25127351 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.24777633 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24646960 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.23841588 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23236920 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22916210 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21663511 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.21272978 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19973713 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18299580 |
| 121 | Basal transcription factors_Homo sapiens_hsa03022 | 0.17829655 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17526536 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.17024106 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16598917 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.14748587 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.14100229 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.13742654 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.13447239 |
| 129 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.12162369 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.10805226 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.09579204 |
| 132 | Melanogenesis_Homo sapiens_hsa04916 | 0.09427034 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.09369926 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.09188033 |

